Mineral Resources International, Inc. Issues Cease and Desist to Desquera Worldwide Regarding Unlawful Use of Trademarks in Malaysia

Mineral Resources International, Inc. Issues Cease and Desist to Desquera Worldwide Regarding Unlawful Use of Trademarks in Malaysia Mineral Resources International, Inc. (MRI) announced it has directed the issuance of a cease and desist letter to Desquera Worldwide Sdn Bhd regarding the sale of products labeled with the Trace Minerals Research® and ConcenTrace® brand names.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava Canada: New Approach to Compendial Reviews Canada's Natural Health Products Directorate (NHPD) has announced that it has adopted a new approach to the review of compendial Product Licence Applications. Canada: New Approach to Compendial Reviews Canada's Natural Health Products Directorate (NHPD) has announced that it has adopted a new approach to the review of compendial Product Licence Applications. Canada: New Approach to Compendial Reviews Canada's Natural Health Products Directorate (NHPD) has announced that it has adopted a new approach to the review of compendial Product Licence Applications. Stryka Botanics Removes Suit Filed by Certified Natural Laboratories Stryka Botanics has filed papers with the United States District Court to remove the suit filed by Certified Natural Laboratories, a supplement manufacturer based in Wichita, Kan., alleging that Stryka delivered to them a fake hoodia gordonii shipment. Stryka Botanics Removes Suit Filed by Certified Natural Laboratories Stryka Botanics has filed papers with the United States District Court to remove the suit filed by Certified Natural Laboratories, a supplement manufacturer based in Wichita, Kan., alleging that Stryka delivered to them a fake hoodia gordonii shipment. Stryka Botanics Removes Suit Filed by Certified Natural Laboratories Stryka Botanics has filed papers with the United States District Court to remove the suit filed by Certified Natural Laboratories, a supplement manufacturer based in Wichita, Kan., alleging that Stryka delivered to them a fake hoodia gordonii shipment. NAD Reviews Advertising for ‘Immunasure’ NAD Reviews Advertising for ‘Immunasure’ NAD Reviews Advertising for ‘Immunasure’ NAD Reviews Advertising for ‘Immunasure’ Pharmaceutical Consulting Services, LLC offers a new “cost effective” concept in GMP Compliance Pharmaceutical Consulting Services, LLC is presenting a program in which for a very small monthly fee, PCS conducts quarterly GMP audits, issues audit reports with non-compliance issues clearly indicated, and works with the company’s staff in finding solutions for the non-compliance issues. Pharmaceutical Consulting Services, LLC offers a new “cost effective” concept in GMP Compliance Pharmaceutical Consulting Services, LLC is presenting a program in which for a very small monthly fee, PCS conducts quarterly GMP audits, issues audit reports with non-compliance issues clearly indicated, and works with the company’s staff in finding solutions for the non-compliance issues. Pharmaceutical Consulting Services, LLC offers a new “cost effective” concept in GMP Compliance Pharmaceutical Consulting Services, LLC is presenting a program in which for a very small monthly fee, PCS conducts quarterly GMP audits, issues audit reports with non-compliance issues clearly indicated, and works with the company’s staff in finding solutions for the non-compliance issues. Pharmaceutical Consulting Services, LLC offers a new “cost effective” concept in GMP Compliance Pharmaceutical Consulting Services, LLC is presenting a program in which for a very small monthly fee, PCS conducts quarterly GMP audits, issues audit reports with non-compliance issues clearly indicated, and works with the company’s staff in finding solutions for the non-compliance issues. Pharmaceutical Consulting Services, LLC offers a new “cost effective” concept in GMP Compliance Pharmaceutical Consulting Services, LLC is presenting a program in which for a very small monthly fee, PCS conducts quarterly GMP audits, issues audit reports with non-compliance issues clearly indicated, and works with the company’s staff in finding solutions for the non-compliance issues. Pharmaceutical Consulting Services, LLC offers a new “cost effective” concept in GMP Compliance Pharmaceutical Consulting Services, LLC is presenting a program in which for a very small monthly fee, PCS conducts quarterly GMP audits, issues audit reports with non-compliance issues clearly indicated, and works with the company’s staff in finding solutions for the non-compliance issues. First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007. First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007. First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007. First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007. First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007. First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007. Sabinsa Corporation Receives GRAS Notification for its Branded Ingredient Cococin(TM) Sabinsa Corporation has announced that it has received Generally Recognized As Safe (GRAS) status for its branded ingredient Cococin(TM), coconut water solids, after an intensive review of safety and toxicology data by an independent panel of respected scientists assembled by Soni & Associates, Inc. Sabinsa Corporation Receives GRAS Notification for its Branded Ingredient Cococin(TM) Sabinsa Corporation has announced that it has received Generally Recognized As Safe (GRAS) status for its branded ingredient Cococin(TM), coconut water solids, after an intensive review of safety and toxicology data by an independent panel of respected scientists assembled by Soni & Associates, Inc. Sabinsa Corporation Receives GRAS Notification for its Branded Ingredient Cococin(TM) Sabinsa Corporation has announced that it has received Generally Recognized As Safe (GRAS) status for its branded ingredient Cococin(TM), coconut water solids, after an intensive review of safety and toxicology data by an independent panel of respected scientists assembled by Soni & Associates, Inc. Sabinsa Corporation Receives GRAS Notification for its Branded Ingredient Cococin(TM) Sabinsa Corporation has announced that it has received Generally Recognized As Safe (GRAS) status for its branded ingredient Cococin(TM), coconut water solids, after an intensive review of safety and toxicology data by an independent panel of respected scientists assembled by Soni & Associates, Inc. Sabinsa Corporation Receives GRAS Notification for its Branded Ingredient Cococin(TM) Sabinsa Corporation has announced that it has received Generally Recognized As Safe (GRAS) status for its branded ingredient Cococin(TM), coconut water solids, after an intensive review of safety and toxicology data by an independent panel of respected scientists assembled by Soni & Associates, Inc. HHS Announces New International Programs to Enhance Drug and Food Safety U.S. Health and Human Services (HHS) Secretary Mike Leavitt has announced two groundbreaking programs designed to enhance the safety of food and medical products exported to the United States- Joint Inspections with European Union and Australian Regulators and a Third-Party Certification Program. HHS Announces New International Programs to Enhance Drug and Food Safety U.S. Health and Human Services (HHS) Secretary Mike Leavitt has announced two groundbreaking programs designed to enhance the safety of food and medical products exported to the United States- Joint Inspections with European Union and Australian Regulators and a Third-Party Certification Program. Larch arabinogalactan from Larix laricina and Larix occidentalis has been approved by the Australian Authorities and is now listed as Therapeutic Goods The Australian Authorities announced on July 8th that Larch arabinogalactan is now approved as a therapeutically active ingredient for oral use. Three requirements have to be met for approval all of which are fulfilled by Lonza’s active ingredient: the ingredient arabinogalactan (Larix) is derived from Larix larcinia or Larix occidentalis; the concentration of polysaccharides in the ingredient arabinogalactan (Larix) is greater than or equal to 85%; and the maximum recommended daily dose of the ingredient arabinogalactan (Larix) is not to exceed 15 grams. Larch arabinogalactan from Larix laricina and Larix occidentalis has been approved by the Australian Authorities and is now listed as Therapeutic Goods The Australian Authorities announced on July 8th that Larch arabinogalactan is now approved as a therapeutically active ingredient for oral use. Three requirements have to be met for approval all of which are fulfilled by Lonza’s active ingredient: the ingredient arabinogalactan (Larix) is derived from Larix larcinia or Larix occidentalis; the concentration of polysaccharides in the ingredient arabinogalactan (Larix) is greater than or equal to 85%; and the maximum recommended daily dose of the ingredient arabinogalactan (Larix) is not to exceed 15 grams. Larch arabinogalactan from Larix laricina and Larix occidentalis has been approved by the Australian Authorities and is now listed as Therapeutic Goods The Australian Authorities announced on July 8th that Larch arabinogalactan is now approved as a therapeutically active ingredient for oral use. Three requirements have to be met for approval all of which are fulfilled by Lonza’s active ingredient: the ingredient arabinogalactan (Larix) is derived from Larix larcinia or Larix occidentalis; the concentration of polysaccharides in the ingredient arabinogalactan (Larix) is greater than or equal to 85%; and the maximum recommended daily dose of the ingredient arabinogalactan (Larix) is not to exceed 15 grams. Larch arabinogalactan from Larix laricina and Larix occidentalis has been approved by the Australian Authorities and is now listed as Therapeutic Goods The Australian Authorities announced on July 8th that Larch arabinogalactan is now approved as a therapeutically active ingredient for oral use. Three requirements have to be met for approval all of which are fulfilled by Lonza’s active ingredient: the ingredient arabinogalactan (Larix) is derived from Larix larcinia or Larix occidentalis; the concentration of polysaccharides in the ingredient arabinogalactan (Larix) is greater than or equal to 85%; and the maximum recommended daily dose of the ingredient arabinogalactan (Larix) is not to exceed 15 grams. IADSA workshop keeps the focus on Latin America Regulators from Argentina, Chile and Brazil have taken part in workshop in Argentina organised by the International Alliance of Dietary/Food Supplement Associations (IADSA) to address global, regional and national regulatory trends. Held last month in Buenos Aires, the workshop gave the representatives the opportunity to learn about other regulatory systems in the area of dietary supplements. IADSA workshop keeps the focus on Latin America Regulators from Argentina, Chile and Brazil have taken part in workshop in Argentina organised by the International Alliance of Dietary/Food Supplement Associations (IADSA) to address global, regional and national regulatory trends. Held last month in Buenos Aires, the workshop gave the representatives the opportunity to learn about other regulatory systems in the area of dietary supplements. Defendants in International Spam Operation Settle FTC Charges; New Canadian Defendants Identified Defendants in an operation that sold bogus weight loss supplements through illegal spam e-mail have settled Federal Trade Commission charges that their operation violated federal laws. The settlement bars them from making false or unsubstantiated claims about health benefits of any food, drug, or dietary supplements; bars violations of the Controlling the Assault of Non-Solicited Pornography and Marketing Act of 2003, known as the CAN-SPAM Act; and requires them to give up $29,000 in ill-gotten gains. Defendants in International Spam Operation Settle FTC Charges; New Canadian Defendants Identified Defendants in an operation that sold bogus weight loss supplements through illegal spam e-mail have settled Federal Trade Commission charges that their operation violated federal laws. The settlement bars them from making false or unsubstantiated claims about health benefits of any food, drug, or dietary supplements; bars violations of the Controlling the Assault of Non-Solicited Pornography and Marketing Act of 2003, known as the CAN-SPAM Act; and requires them to give up $29,000 in ill-gotten gains. Clarinol(TM) CLA: Now GRAS-Approved Lipid Nutrition has announced that FDA has issued a ‘no objection letter’ to the GRAS petition for Clarinol(TM) CLA, confirming its 'GRAS' status. Clarinol(TM) CLA: Now GRAS-Approved Lipid Nutrition has announced that FDA has issued a ‘no objection letter’ to the GRAS petition for Clarinol(TM) CLA, confirming its 'GRAS' status. Clarinol(TM) CLA: Now GRAS-Approved Lipid Nutrition has announced that FDA has issued a ‘no objection letter’ to the GRAS petition for Clarinol(TM) CLA, confirming its 'GRAS' status. Clarinol(TM) CLA: Now GRAS-Approved Lipid Nutrition has announced that FDA has issued a ‘no objection letter’ to the GRAS petition for Clarinol(TM) CLA, confirming its 'GRAS' status. Clarinol(TM) CLA: Now GRAS-Approved Lipid Nutrition has announced that FDA has issued a ‘no objection letter’ to the GRAS petition for Clarinol(TM) CLA, confirming its 'GRAS' status. Federal Authorities Seize Xiadafil VIP Tablets After Company Refuses to Recall Product At the request of the U.S. Food and Drug Administration, U.S. Marshals seized nearly $74,000 worth of Xiadafil VIP tablets, Lots 6K029 and 6K209-SEI, distributed by SEI Pharmaceuticals, Inc. of Miami, Fla. Although marketed as a dietary supplement to treat erectile dysfunction (ED) and for sexual enhancement, these lots represent an illegally marketed drug containing an undeclared ingredient. Federal Authorities Seize Xiadafil VIP Tablets After Company Refuses to Recall Product At the request of the U.S. Food and Drug Administration, U.S. Marshals seized nearly $74,000 worth of Xiadafil VIP tablets, Lots 6K029 and 6K209-SEI, distributed by SEI Pharmaceuticals, Inc. of Miami, Fla. Although marketed as a dietary supplement to treat erectile dysfunction (ED) and for sexual enhancement, these lots represent an illegally marketed drug containing an undeclared ingredient. Federal Authorities Seize Xiadafil VIP Tablets After Company Refuses to Recall Product At the request of the U.S. Food and Drug Administration, U.S. Marshals seized nearly $74,000 worth of Xiadafil VIP tablets, Lots 6K029 and 6K209-SEI, distributed by SEI Pharmaceuticals, Inc. of Miami, Fla. Although marketed as a dietary supplement to treat erectile dysfunction (ED) and for sexual enhancement, these lots represent an illegally marketed drug containing an undeclared ingredient. Federal Authorities Seize Xiadafil VIP Tablets After Company Refuses to Recall Product At the request of the U.S. Food and Drug Administration, U.S. Marshals seized nearly $74,000 worth of Xiadafil VIP tablets, Lots 6K029 and 6K209-SEI, distributed by SEI Pharmaceuticals, Inc. of Miami, Fla. Although marketed as a dietary supplement to treat erectile dysfunction (ED) and for sexual enhancement, these lots represent an illegally marketed drug containing an undeclared ingredient. Cognis’ Tonalin® CLA Achieves FDA GRAS Status Cognis Nutrition and Health has announced that the U.S. Food and Drug Administration (FDA) issued a ‘no questions letter’ to Cognis’ GRAS notification (GRN 00232). Cognis’ Tonalin® CLA Achieves FDA GRAS Status Cognis Nutrition and Health has announced that the U.S. Food and Drug Administration (FDA) issued a ‘no questions letter’ to Cognis’ GRAS notification (GRN 00232). Cognis’ Tonalin® CLA Achieves FDA GRAS Status Cognis Nutrition and Health has announced that the U.S. Food and Drug Administration (FDA) issued a ‘no questions letter’ to Cognis’ GRAS notification (GRN 00232). Cognis’ Tonalin® CLA Achieves FDA GRAS Status Cognis Nutrition and Health has announced that the U.S. Food and Drug Administration (FDA) issued a ‘no questions letter’ to Cognis’ GRAS notification (GRN 00232). Cognis’ Tonalin® CLA Achieves FDA GRAS Status Cognis Nutrition and Health has announced that the U.S. Food and Drug Administration (FDA) issued a ‘no questions letter’ to Cognis’ GRAS notification (GRN 00232). Cognis’ Tonalin® CLA Achieves FDA GRAS Status Cognis Nutrition and Health has announced that the U.S. Food and Drug Administration (FDA) issued a ‘no questions letter’ to Cognis’ GRAS notification (GRN 00232). Cognis’ Tonalin® CLA Achieves FDA GRAS Status Cognis Nutrition and Health has announced that the U.S. Food and Drug Administration (FDA) issued a ‘no questions letter’ to Cognis’ GRAS notification (GRN 00232). Cognis’ Tonalin® CLA Achieves FDA GRAS Status Cognis Nutrition and Health has announced that the U.S. Food and Drug Administration (FDA) issued a ‘no questions letter’ to Cognis’ GRAS notification (GRN 00232). Novel food catalogue clarity reassuring but concerns remain says EHPM European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient. Novel food catalogue clarity reassuring but concerns remain says EHPM European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient. Novel food catalogue clarity reassuring but concerns remain says EHPM European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient. Novel food catalogue clarity reassuring but concerns remain says EHPM European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient. Novel food catalogue clarity reassuring but concerns remain says EHPM European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient. Novel food catalogue clarity reassuring but concerns remain says EHPM European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient. Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA). Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA). Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA). Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA). Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA). EAS Gives Regulatory Crash Course International food and nutrition policy consultancy EAS will be hosting a workshop entitled ‘Building a Regulatory Strategy for Marketing Food Supplements in Europe: The key steps to a successful product launch,’ October 9th, in Brussels. EAS Gives Regulatory Crash Course International food and nutrition policy consultancy EAS will be hosting a workshop entitled ‘Building a Regulatory Strategy for Marketing Food Supplements in Europe: The key steps to a successful product launch,’ October 9th, in Brussels. EAS Gives Regulatory Crash Course International food and nutrition policy consultancy EAS will be hosting a workshop entitled ‘Building a Regulatory Strategy for Marketing Food Supplements in Europe: The key steps to a successful product launch,’ October 9th, in Brussels. EAS Gives Regulatory Crash Course International food and nutrition policy consultancy EAS will be hosting a workshop entitled ‘Building a Regulatory Strategy for Marketing Food Supplements in Europe: The key steps to a successful product launch,’ October 9th, in Brussels. EAS Gives Regulatory Crash Course International food and nutrition policy consultancy EAS will be hosting a workshop entitled ‘Building a Regulatory Strategy for Marketing Food Supplements in Europe: The key steps to a successful product launch,’ October 9th, in Brussels. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	July 22, 2008, Ogden, UT —Mineral Resources International, Inc. (MRI) announced it has directed the issuance of a cease and desist letter to Desquera Worldwide Sdn Bhd regarding the sale of products labeled with the Trace Minerals Research® and ConcenTrace® brand names. Internationally, MRI is maintaining its position that MRI and its predecessors and or assignees (collectively also referred to as MRI) are the only parties that have the exclusive rights to use the Trace Minerals Research brand and ConcenTrace® trade marks as they are sole owners under Trade Mark Registration Nos. 94-08799 and 94-08802 respectively in Malaysia. Trace Minerals Research, L.C. (TMR, L.C.) and its international affiliates, companies, officers, agents, etc. are not authorized to sell, market, distribute, produce, or offer to sell products with the above-listed MRI Malaysian registered trademarks in Malaysia. Bruce Anderson, president/CEO of MRI stated, “When the Andersons sold off the U.S. health-food-store marketing company, they did so with certain clear restrictions. While Mssrs. Matt Kilts, Scott Perkes, and Craig Miles had exclusive rights to the U.S. health-food-store market, the Andersons retained ownership of product formulas in addition to certain trademarks and worked closely with their local marketing partners in various countries to establish and build the international markets using the same brand names, which were not included in the sale of the U.S. health-food-store market to TMR L.C. TMR, L.C. has entered our international markets and tried to capitalize on the MRI goodwill and value that has never belonged to TMR, L.C.” This is the second cease and desist letter MRI has issued against TMR, L.C. and/or one of its distributors regarding the unlawful use of trademarks outside of the United States. In April of 2007, MRI issued a cease and desist letter to TMR, L.C., and ECOMAX Nutrition located in Canada. MRI again reiterates to TMR, L.C, Desquera Worldwide, TMR L.C.’s new supplier, and the international agents of TMR, L.C. that it will not hesitate to pursue further action including injunctions, damages, interests and costs for use of MRI marks, formulas, and products outside of the United States health-food-store market. About Mineral Resources International: Founded through a parent company in 1967 by the Anderson family, Mineral Resources International, Inc. (MRI) (www.mineralresourcesint.com) specializes in developing, manufacturing, and distributing noteworthy nutritional supplements in liquid, tablet, and powder delivery forms integrating naturally occurring minerals and trace minerals harvested from Utah’s Great Salt Lake. Through its close relationship with Northshore Limited Partnership, its exclusive supplier and the only government-inspected, food-grade, solar evaporation mineral harvester on the Great Salt Lake, MRI, Inc. goes to great lengths to ensure an all-natural, GRAS (Generally Recognized as Safe)-certified mineral and trace mineral product while maintaining consistent standardization, concentration, and balance in each lot of product produced. MRI, Inc. manufactures a complete line of innovative dietary supplements ranging from multi-vitamins to targeted nutritional formulas using all-natural ionic minerals. In addition, MRI, Inc. provides a complete portfolio of natural ionic mineral ingredients for use in supplement, functional beverages and foods. MRI’s products are sold worldwide through a variety of distribution channels including natural products and specialty retail stores, salons and estheticians, and natural health care practitioners.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software